Generate a tailored SOP for Dr. Suzanne Turner. Improve your application with a focused, well-structured draft.
Suzanne D. Turner obtained her PhD from the Paterson Institute for Cancer Research, focusing on the potential toxic side effects of chemoprotective gene therapy. Following a position at AstraZeneca, she shifted her research to the Babraham Institute under Dr. Denis Alexander, investigating the mechanisms of Lymphomagenesis. In 2005, she established an academic research group at the University of Cambridge's Department of Pathology. As a leading expert in paediatric lymphomas, particularly Anaplastic Large Cell Lymphoma (ALCL), her work includes developing novel therapeutic approaches and understanding the genetic factors driving these cancers. Over the years, she has received numerous accolades, including the prestigious Leukaemia Lymphoma Research Bennett Fellowship and a senior lectureship award, which underscores her contributions to the field. She collaborates with various international research groups, notably in Uganda, and is involved in significant initiatives like the European Research Initiative for ALCL and the ALKATRAS training network. In addition to her research, Suzanne directs teaching activities within her department and has developed several courses addressing cancer biology and pathology.
Department of Pathology, University of Cambridge • Cambridge, ENG
Oversaw teaching and curriculum development within the Department.
Department of Pathology, University of Cambridge • Cambridge, ENG
Leads a research group focusing on ALCL and related therapies.
Standard postgraduate requirements for Department of Politics and International Studies (POLIS) and related humanities departments.